PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Aligos Belgium BV, Leuven, Belgium. Electronic address: kvandyck@aligos.com.\', \'Aligos Therapeutics, Inc., South San Francisco, USA. Electronic address: jdeval@aligos.com.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1879-6257(21)00040-710.1016/j.coviro.2021.04.006
?:hasPublicationType
?:journal
  • Current opinion in virology
is ?:pmid of
?:pmid
?:pmid
  • 34029993
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.69
?:rankingScore_hIndex
  • 50
is ?:relation_isRelatedTo_publication of
?:title
  • Considerations for the discovery and development of 3-chymotrypsin-like cysteine protease inhibitors targeting SARS-CoV-2 infection.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34029993>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34029993>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all